Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA1D | P25100 | 13/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 13/20 | 0.49 |
| ▸ | ADRA1B | P35368 | 13/20 | 0.49 |
| ▸ | HTR1A | P08908 | 12/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.44 |
| ▸ | BPTF | Q12830 | 1/20 | 0.43 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9526736 | 0.88 | ADRA1A (0.62) | ADRA1DADRA1AADRA1BHTR1ADRD2 | |
| SCHEMBL9527491 | 0.87 | KAT2B (0.53) | ADRA1DADRA1AADRA1BHTR1AHTR1B | |
| SCHEMBL9531556 | 0.83 | ADRA1A (0.53) | ADRA1DADRA1AADRA1BHTR1ABPTF | |
| SCHEMBL9526823 | 0.82 | HTR1A (0.64) | ADRA1DADRA1AADRA1BHTR1AHTR6 | |
| SCHEMBL27263986 | 0.82 | HTR1A (0.43) | ADRA1DADRA1AADRA1BHTR1ABCHE | |
| SCHEMBL27263416 | 0.82 | HTR1A (0.47) | ADRA1DADRA1AADRA1BHTR1A | |
| SCHEMBL9528184 | 0.82 | ADRA1A (0.58) | ADRA1DADRA1AADRA1BHTR1ABPTF | |
| SCHEMBL9528841 | 0.82 | ADRA1B (0.55) | ADRA1DADRA1AADRA1BHTR1ABPTF | |
| SCHEMBL9527725 | 0.81 | HTR1A (0.60) | ADRA1DADRA1AADRA1BHTR1AHTR6 | |
| SCHEMBL9527024 | 0.81 | BPTF (0.53) | ADRA1DADRA1AADRA1BHTR1ABPTF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0372305-B1 | PIPERAZINYLALKYL-3(2H)-PYRIDAZINONES, METHOD FOR THEIR PREPARATION AND THEIR USE AS ANTIHYPERTENSIVE AGENTS | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1993-08-04 | — | — | EP | disclosed |
| US-5034391-A | Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure | CL PHARMA AKTIENGESELLSCHAFT (AT) | 1991-07-23 | — | — | US | disclosed |
| EP-0372305-A1 | Piperazinylalkyl-3(2H)-pyridazinones, method for their preparation and their use as antihypertensive agents | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1990-06-13 | — | — | EP | disclosed |